Company’s Patent Makes Cancer Test 
Too Expensive

June 19, 2013
by
1 min read
Folio Weekly

Until recently, apparently, gene mutations were considered merely freaks of nature, but that was before Myriad Genetics obtained binding U.S. patents for mutations it discovered — now known as BRCA-1 and BRCA-2. Those mutations were in the news in May when actor Angelina Jolie announced that she had chosen to have a double mastectomy based on the presence of the cancer-causing mutations, which she had learned of through a Myriad Genetics test costing about $4,000. There is no price competition for the test, due to the patent, and Jolie, along with oncologists and OB-GYN doctors, fret that the test is too expensive for tens of millions of women around the world whose lives could be saved by knowing their status.

Folio is your guide to entertainment and culture around and near Jacksonville, Florida. We cover events, concerts, restaurants, theatre, sports, art, happenings, and all things about living and visiting Jax. Folio serves more than two million readers across Jacksonville and Northeast Florida, including St. Augustine, The Beaches, and Fernandina.

Current Issue

SUBMIT EVENTS

Submit Events

Advertisements

SingOutLoadFestival_TheAmp_2025
liz-buys-houses-digital
generac-home-standby-generator-banners

Date

Title

Current Month

Follow FOLIO!

Folio Weekly
Previous Story

PISCES: June 19-25

Next Story

Bridging the Gap

Latest from Imported Folio

Pandemic could put Jaguars’ traditions on ‘timeout’

Lindsey Nolen Remember the basketball game HORSE? Well, on Thursday nights during the National Football League regular season the Jacksonville Jaguars’ offensive line comes together for their own version of the game, “CAT.” They’ve also been known to play a game of Rock Band or two. This is because on
Folio Weekly

September Digital Issue

Attachments 20201106-190334-Folio October Issue 6 for ISSU and PDF EMAIL BLAST COMPRESSED.pdf Click here to view the PDF!
July 5th Cleanup
GoUp